NCT05047536 2025-12-19KZR-261 in Subjects With Advanced Solid MalignanciesKezar Life Sciences, Inc.Phase 1 Terminated61 enrolled 25 charts
NCT02751528 2025-01-13QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast CancerNantBioScience, Inc.Phase 1 Terminated3 enrolled 10 charts